S
Stephen G. Ellis
Researcher at Cleveland Clinic
Publications - 668
Citations - 67828
Stephen G. Ellis is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 127, co-authored 655 publications receiving 65073 citations. Previous affiliations of Stephen G. Ellis include Scripps Health & Brown University.
Papers
More filters
Journal ArticleDOI
Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors
A.M. Lincoff,Robert M. Califf,David J. Moliterno,Stephen G. Ellis,John Ducas,Kramer Jh,Neal S. Kleiman,Eric A. Cohen,Joan E. Booth,Shelly Sapp,Catherine F. Cabot,Eric J. Topol +11 more
TL;DR: Among patients with diabetes, the combination of abciximab and stenting was associated with a lower rate of repeated target-vessel revascularization than was stenting and placebo or angioplasty and abcximab.
Journal ArticleDOI
Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention
Eric J. Topol,James J. Ferguson,Harlan F. Weisman,James E. Tcheng,Stephen G. Ellis,Neal S. Kleiman,Russell J. Ivanhoe,Ann L. Wang,David P. Miller,Keaven M. Anderson,Robert M. Califf +10 more
TL;DR: Adciximab bolus with infusion given at the time of coronary angioplasty improves outcomes as long as 3 years after the procedure, and death rates increased as periprocedural creatine kinase levels increased.
Journal ArticleDOI
Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction.
Stephen G. Ellis,E R da Silva,G Heyndrickx,J D Talley,Carmelo Cernigliaro,G Steg,Christian Spaulding,M Nobuyoshi,R Erbel,C Vassanelli +9 more
TL;DR: When applied to patients with first anterior infarction, rescue angioplasty appears to be useful in the prevention of death or severe heart failure, with improvement in exercise, but not resting, ejection fraction.
Journal ArticleDOI
Combined Accelerated Tissue-Plasminogen Activator and Platelet Glycoprotein IIb/IIIa Integrin Receptor Blockade With Integrilin in Acute Myocardial Infarction Results of a Randomized, Placebo-Controlled, Dose-Ranging Trial
E. Magnus Ohman,Neal S. Kleiman,Gerald Gacioch,Seth J. Worley,Frank I. Navetta,J. David Talley,H. Vernon Anderson,Stephen G. Ellis,Mark D. Cohen,Douglas Spriggs,Michael F Miller,Dean J. Kereiakes,Steven J. Yakubov,Michael M. Kitt,Kristina N. Sigmon,Robert M. Califf,Mitchell W. Krucoff,Eric J. Topol +17 more
TL;DR: The incidence and speed of reperfusion can be enhanced when a potent inhibitor of the glycoprotein IIb/IIIa integrin receptor, such as Integrilin, is combined with accelerated alteplase, aspirin, and intravenous heparin.
Journal ArticleDOI
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting
Deepak L. Bhatt,Michel E. Bertrand,Peter B. Berger,Philippe L. L’Allier,Issam Moussa,Jeffrey W. Moses,George Dangas,Megumi Taniuchi,John M. Lasala,David R. Holmes,Stephen G. Ellis,Eric J. Topol +11 more
TL;DR: Based on all available evidence from randomized clinical trials or registries, clopidogrel plus aspirin should replace ticlopidine plus aspirin as the standard antiplatelet regimen after stent deployment.